Retrospective Study
Copyright ©The Author(s) 2021.
World J Cardiol. Sep 26, 2021; 13(9): 493-502
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.493
Table 3 Procedural features and outcomes
Feature
n (%)
Anticoagulation
Heparin only12 (34)
Bivalirudin8 (23)
Heparin + GP IIb IIIa inhibitor15 (43)
Thrombectomy20 (57)
Distal protection device9 (26)
Number of stents (mean ± SD)2.1 ± 1.3
Total stent length (mean ± SD)52 ± 35 mm
Stent type
Drug-eluting19 (55)
Bare metal11 (31)
None5 (14)
Procedural outcome
Success29 (83)
Failed6 (17)
Procedural complications
Distal embolization1 (3)
No reflow5 (15)
In-hospital MACE
Death2 (5.7)
Myocardial infarction1 (2.9)
Stroke0
Repeat PCI or CABG0
Any MACE3 (8.6)